With your financial support, our goal is to improve the understanding and treatment of psychiatric and neuropsychiatric disorders through the discovery of clinically useful autoantibody biomarkers. There is a significant need for biomarkers that can help diagnose, predict outcomes, and guide treatment choices for conditions like bipolar disorder and other neuropsychiatric diseases. These efforts have the potential to lead to more effective treatments and better outcomes for patients suffering from these debilitating conditions.